首页 | 本学科首页   官方微博 | 高级检索  
检索        

类风湿关节炎疗效的追踪观察
引用本文:余步云,黄建林,吴启富,李翠贞,陶怡,陈玉琼.类风湿关节炎疗效的追踪观察[J].中国药物与临床,2001,1(1):13-15.
作者姓名:余步云  黄建林  吴启富  李翠贞  陶怡  陈玉琼
作者单位:1. 中山医科大学附属第三医院风湿科,510630
2. 第一军医大学南方医院风湿科,510630
3. 广州市第一人民医院风湿科,510630
4. 广州医学院第二附属医院风湿科,510630
5. 暨南大学附属华侨医院风湿科,510630
摘    要:目的 观察甲氨蝶呤(MTX)、柳氮磺吡啶(SASP)、金诺芬、雷公藤多甙、糖皮质激素和重组人干扰素-γ不同联合治疗方案对类风湿关节炎(RA)的远期疗效。方法①对189例经冶疗后追踪1~6年的RA病例进行回顾性分析;②治疗方案:基础治疗方案为MTX加SASP,MTX加金诺芬,部分病例合并使用雷公藤多甙、糖皮质激素、重组人干扰素-γ;③观察指标:关节临床表现、实验室检查(ESR、CRP、RF滴度)和关节X线片。结果①全组临床疗效评价:症状缓解11.1%、基本控制49.7%、进步27.0%、反复发作或恶化12.2%;②X线评价:122例作X线复查。X线改善6.9%、无改变77,8%、进展17.2 %;③单纯基础治疗组与加用雷公藤多甙或糖皮质激素组比较,其远期临床疗效和X线变化,两者差异均无显著性;④并用重组人干扰素-γ组22例。临床疗效:症状缓解45.5%、进步40.9%、反复发作或恶化13.6%X线评价:改善1例,余均无改变。结论①对RA采用综合性治疗可取得较满意的疗效;②在基础治疗上加用雷公藤多甙或糖皮质激素,对远期临床疗效和X线变化无明显影响;应用重组人干扰素-γ与其他二线药合用在一定程度上有扭转病情发展,取?

关 键 词:关节炎  类风湿  治疗  远期追踪
修稿时间:2001年1月8日

A follow-up study of rheumatoid arthritis
Abstract:Objective To investigate long effect of combination therapy. Method ① A retrospective analysis was made in 189 cases being followed up for more than 1 year. Of them, 115 cases were followed up for 2~6 years. ② The combinations of methothexate (MTX) and sulphasalazine (SASP) or MIX and ridaura (auranofin) were used as fundamental treatment. Chinese herbal preparatoin, tripterygium glycosides or glucocorticoid, prednisone was added in some cases. Interferon (INF-γ) was added as a course treatment (3~6 months) in 22 cases. ③ Arthral manifestations, laboratory changes (ESR, CRP, RF), as well as X-ray examination were used as observing indexes. ④ Therapeutic effect was evaluated by both clinical manifestations and radiographic findings. Results ①Clinical evaluation of 189 cases, 11 . 1% with a relief of symptoms, 49 . 7% with a favorite control of the clinical manifestations, 27. 0% with improvement of symptoms and 12.2% with deterioration. ② As for radiological study, of 122 cases with recheck of X-ray at the end of the study, 4.9% with a certain extent of improvement, 77.8% without obvious changes and 17.2% with some deterioration. ③ There were no noticeable differences in late result and radiographic changes between the fundamental group and those who received additive tripterygium glycosides or glucocorticoids (P <0.05) - 22 ④cases who had received additional recombinant human INF-γ showed a clinical effect: remission 45.5 %, improvement 40.9 %, repeated attack or exacerbation 13.6 % and a radiographic finding: 1 case improved, the rest remained unchanged. Conclusion ① This study shows a rather good effect by adopting the above combination therapy. ② Tripterygium glycosides and glucocorticoid may have a short-term effect in improving symptoms, but without effect in long-term treatment and on radiographic findings. ③ INF-γ may be a good drug for relieving symptoms, winning a stable or even improved radiographic finding.
Keywords:Arthtitis  rheumatoid  Treatment  Long-term follow-up
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号